title: Oral antiviral therapy reduces the risk of hepatocellular carcinoma in persons with chronic hepatitis B infection: combining evidence and common sense.
authors.affiliation: Beijing Key Laboratory of Translational Medicine on Liver Cirrhosis, Clinical Epidemiology and EBM Unit and Liver Research Center, Beijing Friendship Hospital, National Clinical Research Center of Digestive Diseases, Capital Medical University, Beijing, 100050, People's Republic of China. kongyuanyuan2000@163.com.
authors.forename: Yuanyuan
authors.initials: Y
authors.lastname: Kong
authors.affiliation: Beijing Key Laboratory of Translational Medicine on Liver Cirrhosis, Clinical Epidemiology and EBM Unit and Liver Research Center, Beijing Friendship Hospital, National Clinical Research Center of Digestive Diseases, Capital Medical University, Beijing, 100050, People's Republic of China. youhong30@sina.com.
authors.forename: Hong
authors.initials: H
authors.lastname: You
authors.affiliation: Beijing Key Laboratory of Translational Medicine on Liver Cirrhosis, Clinical Epidemiology and EBM Unit and Liver Research Center, Beijing Friendship Hospital, National Clinical Research Center of Digestive Diseases, Capital Medical University, Beijing, 100050, People's Republic of China. jia_jd@ccmu.edu.cn.
authors.forename: Jidong
authors.initials: J
authors.lastname: Jia
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy*; D006509:Hepatitis B / Q000188:drug therapy; D019694:Hepatitis B, Chronic / Q000188:drug therapy*; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy
chemical_list: D000998:Antiviral Agents